Register Financial Advisors’s Pfizer PFE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.06M	Buy	44,133 +88	+0.2%	+$2.3K	0.33%	82
2026 Q1	$1.24M	Buy	44,045 +3,084	+8%	+$82.1K	0.46%	68
2025 Q4	$1.02M	Buy	40,961 +1,825	+5%	+$46K	0.4%	74
2025 Q3	$997K	Buy	39,136 +449	+1%	+$11.1K	0.39%	71
2025 Q2	$938K	Sell	38,687 -743	-2%	-$17.3K	0.41%	67
2025 Q1	$999K	Sell	39,430 -1,127	-3%	-$29.5K	0.52%	54
2024 Q4	$1.08M	Sell	40,557 -20,637	-34%	-$560K	0.54%	52
2024 Q3	$1.77M	Buy	61,194 +3,174	+5%	+$92.6K	0.91%	30
2024 Q2	$1.62M	Buy	58,020 +1,891	+3%	+$52.1K	0.82%	30
2024 Q1	$1.56M	Buy	56,129 +26,131	+87%	+$725K	0.81%	31
2023 Q4	$864K	Sell	29,998 -2,778	-8%	-$84K	0.58%	48
2023 Q3	$1.09M	Sell	32,776 -823	-2%	-$29.1K	0.8%	38
2023 Q2	$1.23M	Buy	33,599 +407	+1%	+$15.8K	0.88%	31
2023 Q1	$1.35M	Buy	33,192 +3,598	+12%	+$155K	1.06%	21
2022 Q4	$1.52M	Buy	+29,594	New	+$1.42M	0.97%	25

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Register Financial Advisors's PFE Position: Q2 2026 in Review

Register Financial Advisors increased its Pfizer (PFE) stake by 0.2% in Q2 2026, buying an estimated $2.3K and bringing the position to 44,133 shares worth $1.06M. The position accounts for 0.33% of the portfolio, ranked #82.

Register Financial Advisors first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.77M in Q3 2024. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Register Financial Advisors held 44,133 shares of Pfizer worth $1.06M as of Q2 2026.
Register Financial Advisors bought 88 Pfizer shares in Q2 2026, an estimated $2.3K.
Pfizer made up 0.33% of Register Financial Advisors's portfolio in Q2 2026, its #82 holding.
Register Financial Advisors first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
Register Financial Advisors's Pfizer position peaked at $1.77M in Q3 2024.
1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Register Financial Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.